Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

A study published in Human Gene Therapy has involved the generation of a human monoclonal antibody (mAb) directed against ...

The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and ...

A noninvasive approach could help clinicians prescribe medications more precisely for patients according to endotype.

New research reveals why cancer often spreads to the lungs, identifying elevated aspartate levels as a key factor in aiding ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

More than half of cancer patients in whom the cancer spreads beyond the primary site have lung metastases. What makes the ...

A NEW study has identified two key predictors of lung function decline in asthma: rising blood eosinophil counts over time ...

Adults younger than 65 years with esophageal cancer were extremely unlikely to have a previous diagnosis of eosinophilic ...

A recent novel study published in the New England Journal of Medicine found that Depemokimab can reduce asthma exacerbations ...